热休克蛋白110 (HSP110)在结直肠癌中的功能及作用研究进展
Advances in Functional Roles of Heat Shock Protein 110 (HSP110) in Colorectal Cancer
DOI: 10.12677/acm.2025.1551373, PDF,   
作者: 赵瑾瑾, 田 赟*：南京中医药大学附属医院(江苏省中医院)肿瘤内科，江苏 南京
关键词: 热休克蛋白110；结直肠癌；功能作用；综述；Heat Shock Protein 110； Colorectal Cancer； Functional Roles； Review
摘要: 结直肠癌(Colorectal cancer, CRC)在我国及全球范围内的发病率和死亡率均位居前列，其发病率呈不断上升趋势，严重威胁人类健康。传统抗肿瘤治疗手段易产生耐药性，积极寻找新的分子靶点对CRC的防治至关重要。热休克蛋白(Heat shock proteins, HSPs)是一个成员庞大的多肽类蛋白质家族，在细胞内广泛存在，并通过多种途径参与细胞的生理和病理过程。HSP110作为HSPs中的一员，近年研究发现，HSP110在CRC中具有双重角色及机制复杂性的特点，而其在CRC领域的文献相对分散，缺乏系统性综述。本文归纳总结了目前国内外关于HSP110与CRC相关的研究，系统阐述了HSP110在CRC中的功能及作用。我们表明，HSP110在CRC中发挥了双重作用，有望为HSP110在CRC的诊治和研究提供新的思路与帮助。
Abstract: Colorectal cancer (CRC) remains a leading cause of global morbidity and mortality, with a steadily increasing incidence that poses significant public health challenges. Conventional anticancer therapies often develop resistance, highlighting the critical need for novel molecular targets. Heat shock proteins (HSPs), a conserved polypeptide protein family ubiquitously expressed in cells, modulate cellular physiological and pathological processes through diverse mechanisms. Recent studies reveal that HSP110, a member of the HSP family, exhibits dual roles and complex mechanisms in CRC pathogenesis. However, existing literature remains fragmented, lacking systematic synthesis. This review comprehensively reviews current research on HSP110 in CRC and systematically delineates its functional roles. We elucidate the dual regulatory roles of HSP110 in CRC progression and propose novel perspectives for diagnostic and therapeutic strategies targeting HSP110.
文章引用：赵瑾瑾, 田赟. 热休克蛋白110 (HSP110)在结直肠癌中的功能及作用研究进展[J]. 临床医学进展, 2025, 15(5): 314-323. https://doi.org/10.12677/acm.2025.1551373

参考文献

[1] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[2] Wang, Z. and Fang, J. (2014) Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance. Gastrointestinal Tumors, 1, 146-154. [Google Scholar] [CrossRef] [PubMed]
[3] Szyller, J. and Bil-Lula, I. (2015) Heat Shock Proteins in Oxidative Stress and Ischemia/Reperfusion Injury and Benefits from Physical Exercises: A Review to the Current Knowledge. Oxidative Medicine and Cellular Longevity, 6, 101-109.
[4] Wu, Y., Zhao, J., Tian, Y. and Jin, H. (2023) Cellular Functions of Heat Shock Protein 20 (HSPB6) in Cancer: A Review. Cellular Signalling, 112, Article ID: 110928. [Google Scholar] [CrossRef] [PubMed]
[5] Bondy, S.C. (2014) Prolonged Exposure to Low Levels of Aluminum Leads to Changes Associated with Brain Aging and Neurodegeneration. Toxicology, 315, 1-7. [Google Scholar] [CrossRef] [PubMed]
[6] 徐煌, 韩冬, 程惠平. 热休克蛋白110的研究进展[J]. 嘉兴学院学报, 2008, 20(6): 15-17, 73.
[7] Mayer, M.P. and Bukau, B. (2005) Hsp70 Chaperones: Cellular Functions and Molecular Mechanism. Cellular and Molecular Life Sciences, 62, 670-684. [Google Scholar] [CrossRef] [PubMed]
[8] Bukau, B., Weissman, J. and Horwich, A. (2006) Molecular Chaperones and Protein Quality Control. Cell, 125, 443-451. [Google Scholar] [CrossRef] [PubMed]
[9] Young, J.C. (2010) Mechanisms of the Hsp70 Chaperone Systemthis Paper Is One of a Selection of Papers Published in This Special Issue Entitled “Canadian Society of Biochemistry, Molecular & Cellular Biology 52nd Annual Meeting—Protein Folding: Principles and Diseases” and Has Undergone the Journal’s Usual Peer Review Process. Biochemistry and Cell Biology, 88, 291-300. [Google Scholar] [CrossRef] [PubMed]
[10] 杨营. 热休克蛋白Sse1的表达纯化以及生化性质研究[D]: [硕士学位论文]. 天津: 天津科技大学, 2016.
[11] Oh, H.J., Easton, D., Murawski, M., Kaneko, Y. and Subjeck, J.R. (1999) The Chaperoning Activity of Hsp110: Identification of Functional Domains by Use of Targeted Deletions. Journal of Biological Chemistry, 274, 15712-15718. [Google Scholar] [CrossRef] [PubMed]
[12] Javid, H., Hashemian, P., Yazdani, S., Sharbaf Mashhad, A. and Karimi‐Shahri, M. (2022) The Role of Heat Shock Proteins in Metastatic Colorectal Cancer: A Review. Journal of Cellular Biochemistry, 123, 1704-1735. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, X. and Subjeck, J.R. (2013) High Molecular Weight Stress Proteins: Identification, Cloning and Utilisation in Cancer Immunotherapy. International Journal of Hyperthermia, 29, 364-375. [Google Scholar] [CrossRef] [PubMed]
[14] Oh, H.J., Chen, X. and Subjeck, J.R. (1997) Hsp110 Protects Heat-Denatured Proteins and Confers Cellular Thermoresistance. Journal of Biological Chemistry, 272, 31636-31640. [Google Scholar] [CrossRef] [PubMed]
[15] Berthenet, K., Boudesco, C., Collura, A., Svrcek, M., Richaud, S., Hammann, A., et al. (2016) Extracellular HSP110 Skews Macrophage Polarization in Colorectal Cancer. OncoImmunology, 5, e1170264. [Google Scholar] [CrossRef] [PubMed]
[16] Gozzi, G.J., Gonzalez, D., Boudesco, C., Dias, A.M.M., Gotthard, G., Uyanik, B., et al. (2019) Selecting the First Chemical Molecule Inhibitor of HSP110 for Colorectal Cancer Therapy. Cell Death & Differentiation, 27, 117-129. [Google Scholar] [CrossRef] [PubMed]
[17] Chatterjee, S. and Burns, T. (2017) Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach. International Journal of Molecular Sciences, 18, Article 1978. [Google Scholar] [CrossRef] [PubMed]
[18] Berthenet, K., Bokhari, A., Lagrange, A., Marcion, G., Boudesco, C., Causse, S., et al. (2016) HSP110 Promotes Colorectal Cancer Growth through STAT3 Activation. Oncogene, 36, 2328-2336. [Google Scholar] [CrossRef] [PubMed]
[19] Hjerpe, R., Bett, J.S., Keuss, M.J., Solovyova, A., McWilliams, T.G., Johnson, C., et al. (2016) UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. Cell, 166, 935-949. [Google Scholar] [CrossRef] [PubMed]
[20] Abi Zamer, B., El-Huneidi, W., Eladl, M.A. and Muhammad, J.S. (2021) Ins and Outs of Heat Shock Proteins in Colorectal Carcinoma: Its Role in Carcinogenesis and Therapeutic Perspectives. Cells, 10, Article 2862. [Google Scholar] [CrossRef] [PubMed]
[21] Dorard, C., de Thonel, A., Collura, A., Marisa, L., Svrcek, M., Lagrange, A., et al. (2011) Expression of a Mutant HSP110 Sensitizes Colorectal Cancer Cells to Chemotherapy and Improves Disease Prognosis. Nature Medicine, 17, 1283-1289. [Google Scholar] [CrossRef] [PubMed]
[22] Yu, N., Kakunda, M., Pham, V., Lill, J.R., Du, P., Wongchenko, M., et al. (2015) HSP105 Recruits Protein Phosphatase 2A to Dephosphorylate β-Catenin. Molecular and Cellular Biology, 35, 1390-1400. [Google Scholar] [CrossRef] [PubMed]
[23] Bharathi, Shamasundar, N.M., Sathyanarayana Rao, T.S., Dhanunjaya Naidu, M., Ravid, R. and Rao, K.S.J. (2006) A New Insight on Al-Maltolate-Treated Aged Rabbit as Alzheimer’s Animal Model. Brain Research Reviews, 52, 275-292. [Google Scholar] [CrossRef] [PubMed]
[24] Delamarche, C. (1993) A Molecular Mechanism of Aluminum Neurotoxicity. Journal of Neurochemistry, 60, 384-385. [Google Scholar] [CrossRef] [PubMed]
[25] 任发亮, 任巧丽, 田志强, 等. HSP110与肿瘤免疫[J]. 免疫学杂志, 2018, 34(7): 641-644.
[26] Facciponte, J.G., Wang, X. and Subjeck, J.R. (2007) Hsp110 and Grp170, Members of the Hsp70 Superfamily, Bind to Scavenger Receptor‐A and Scavenger Receptor Expressed by Endothelial Cells‐I. European Journal of Immunology, 37, 2268-2279. [Google Scholar] [CrossRef] [PubMed]
[27] Duval, A., Collura, A., Berthenet, K., Lagrange, A. and Garrido, C. (2011) Microsatellite Instability in Colorectal Cancer: Time to Stop Hiding! Oncotarget, 2, 826-827. [Google Scholar] [CrossRef] [PubMed]
[28] Kuang, D., Wu, Y., Chen, N., Cheng, J., Zhuang, S. and Zheng, L. (2007) Tumor-Derived Hyaluronan Induces Formation of Immunosuppressive Macrophages through Transient Early Activation of Monocytes. Blood, 110, 587-595. [Google Scholar] [CrossRef] [PubMed]
[29] Calderwood, S.K., Khaleque, M.A., Sawyer, D.B. and Ciocca, D.R. (2006) Heat Shock Proteins in Cancer: Chaperones of Tumorigenesis. Trends in Biochemical Sciences, 31, 164-172. [Google Scholar] [CrossRef] [PubMed]
[30] Boissière-Michot, F., Lazennec, G., Frugier, H., Jarlier, M., Roca, L., Duffour, J., et al. (2014) Characterization of an Adaptive Immune Response in Microsatellite-Instable Colorectal Cancer. OncoImmunology, 3, e29256. [Google Scholar] [CrossRef] [PubMed]
[31] Berardinelli, G.N., Scapulatempo-Neto, C., Durães, R., Antônio de Oliveira, M., Guimarães, D. and Reis, R.M. (2018) Advantage of HSP110 (T17) Marker Inclusion for Microsatellite Instability (MSI) Detection in Colorectal Cancer Patients. Oncotarget, 9, 28691-28701. [Google Scholar] [CrossRef] [PubMed]
[32] Hosaka, S., Nakatsura, T., Tsukamoto, H., Hatayama, T., Baba, H. and Nishimura, Y. (2006) Synthetic Small Interfering RNA Targeting Heat Shock Protein 105 Induces Apoptosis of Various Cancer Cells Both in Vitro and in Vivo. Cancer Science, 97, 623-632. [Google Scholar] [CrossRef] [PubMed]
[33] Slaby, (2009) Significant Overexpression of Hsp110 Gene during Colorectal Cancer Progression. Oncology Reports, 21, 1235-1241. [Google Scholar] [CrossRef] [PubMed]
[34] Collura, A., Lagrange, A., Svrcek, M., Marisa, L., Buhard, O., Guilloux, A., et al. (2014) Patients with Colorectal Tumors with Microsatellite Instability and Large Deletions in HSP110 T17 Have Improved Response to 5-Fluorouracil-Based Chemotherapy. Gastroenterology, 146, 401-411.e1. [Google Scholar] [CrossRef] [PubMed]
[35] Buhard, O., Lagrange, A., Guilloux, A., Colas, C., Chouchène, M., Wanherdrick, K., et al. (2016) HSP110T17 Simplifies and Improves the Microsatellite Instability Testing in Patients with Colorectal Cancer. Journal of Medical Genetics, 53, 377-384. [Google Scholar] [CrossRef] [PubMed]
[36] Kimura, A., Ogata, K., Altan, B., Yokobori, T., Ide, M., Mochiki, E., et al. (2016) Nuclear Heat Shock Protein 110 Expression Is Associated with Poor Prognosis and Chemotherapy Resistance in Gastric Cancer. Oncotarget, 7, 18415-18423. [Google Scholar] [CrossRef] [PubMed]
[37] Kimura, A., Ogata, K., Altan, B., Yokobori, T., Mochiki, E., Yanai, M., et al. (2017) Nuclear Heat Shock Protein 110 Expression Is Associated with Poor Prognosis and Hyperthermo-Chemotherapy Resistance in Gastric Cancer Patients with Peritoneal Metastasis. World Journal of Gastroenterology, 23, 7541-7550. [Google Scholar] [CrossRef] [PubMed]
[38] Garrido, C., Collura, A., Berthenet, K., Lagrange, A. and Duval, A. (2012) Mutation d’HSP110 dans les cancers colorectaux. Médecine/Sciences, 28, 9-10. [Google Scholar] [CrossRef] [PubMed]
[39] Roma, C., Rachiglio, A.M., Pasquale, R., Fenizia, F., Iannaccone, A., Tatangelo, F., et al. (2016) BRAF V600E Mutation in Metastatic Colorectal Cancer: Methods of Detection and Correlation with Clinical and Pathologic Features. Cancer Biology & Therapy, 17, 840-848. [Google Scholar] [CrossRef] [PubMed]
[40] How-Kit, A., Daunay, A., Buhard, O., Meiller, C., Sahbatou, M., Collura, A., et al. (2017) Major Improvement in the Detection of Microsatellite Instability in Colorectal Cancer Using HSP110 T17 E-ice-COLD-PCR. Human Mutation, 39, 441-453. [Google Scholar] [CrossRef] [PubMed]
[41] Luo, Y., Cheng, B., Liu, S., et al. (2019) Relationship between CpG Island Methylation Phenotype, Microsatellite Instability Phenotype and Mutation of KRAS, NRAS, and BRAF Genes in Colorectal Cancer. International Journal of Clinical and Experimental Pathology, 12, 1101-1107.
[42] Zimmermann, M., Oehler, C., Mey, U., Ghadjar, P. and Zwahlen, D.R. (2016) Radiotherapy for Non-Hodgkin’s Lymphoma: Still Standard Practice and Not an Outdated Treatment Option. Radiation Oncology, 11, Article No. 110. [Google Scholar] [CrossRef] [PubMed]
[43] Causse, S.Z., Marcion, G., Chanteloup, G., Uyanik, B., Boudesco, C., Grigorash, B.B., et al. (2018) HSP110 Translocates to the Nucleus Upon Genotoxic Chemotherapy and Promotes DNA Repair in Colorectal Cancer Cells. Oncogene, 38, 2767-2777. [Google Scholar] [CrossRef] [PubMed]
[44] Kim, K., Lee, T.H., Kim, J.H., Cho, N., Kim, W.H. and Kang, G.H. (2017) Deletion in HSP110 T17: Correlation with Wild-Type HSP110 Expression and Prognostic Significance in Microsatellite-Unstable Advanced Gastric Cancers. Human Pathology, 67, 109-118. [Google Scholar] [CrossRef] [PubMed]
[45] Tachon, G., Chong-Si-Tsaon, A., Lecomte, T., Junca, A., Frouin, É., Miquelestorena-Standley, E., et al. (2022) HSP110 as a Diagnostic but Not a Prognostic Biomarker in Colorectal Cancer with Microsatellite Instability. Frontiers in Genetics, 12, Article 769281. [Google Scholar] [CrossRef] [PubMed]
[46] Chan, A.T. (2011) Turning up the Heat on Colorectal Cancer. Nature Medicine, 17, 1186-1188. [Google Scholar] [CrossRef] [PubMed]
[47] 中国医师协会医学技师委员会病理技术专家组. 微卫星不稳定性(MSI)检测技术专家共识[J]. 临床与实验病理学杂志, 2024, 40(3): 228-235.
[48] Rajoua, N., Daunay, A., Triki, W., Baraket, O., Bouchoucha, S., Maghrebi, H., et al. (2025) HSP110 T17 Marker Matches the Pentaplex Panel and Outperforms CAT-25 for Detecting Microsatellite Instability in Sporadic Colorectal Cancer. Cancer Genetics, 294, 21-26. [Google Scholar] [CrossRef] [PubMed]
[49] Morikawa, T., Baba, Y., Yamauchi, M., Kuchiba, A., Nosho, K., Shima, K., et al. (2011) STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers. Clinical Cancer Research, 17, 1452-1462. [Google Scholar] [CrossRef] [PubMed]
[50] Huang, W., Dong, Z., Chen, Y., Wang, F., Wang, C.J., Peng, H., et al. (2016) Erratum: Small-Molecule Inhibitors Targeting the DNA-Binding Domain of STAT3 Suppress Tumor Growth, Metastasis and STAT3 Target Gene Expression in Vivo. Oncogene, 35, 802-802. [Google Scholar] [CrossRef] [PubMed]
[51] Huet, S., Gorre, H., Perrocheau, A., Picot, J. and Cinier, M. (2015) Use of the Nanofitin Alternative Scaffold as a GFP-Ready Fusion Tag. PLOS ONE, 10, e0142304. [Google Scholar] [CrossRef] [PubMed]
[52] Goux, M., Becker, G., Gorré, H., Dammicco, S., Desselle, A., Egrise, D., et al. (2017) Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors. Bioconjugate Chemistry, 28, 2361-2371. [Google Scholar] [CrossRef] [PubMed]
[53] Marcion, G., Hermetet, F., Neiers, F., Uyanik, B., Dondaine, L., Dias, A.M.M., et al. (2021) Nanofitins Targeting Heat Shock Protein 110: An Innovative Immunotherapeutic Modality in Cancer. International Journal of Cancer, 148, 3019-3031. [Google Scholar] [CrossRef] [PubMed]
[54] Kelly, M., McNeel, D., Fisch, P. and Malkovsky, M. (2018) Immunological Considerations Underlying Heat Shock Protein-Mediated Cancer Vaccine Strategies. Immunology Letters, 193, 1-10. [Google Scholar] [CrossRef] [PubMed]
[55] Ciocca, D.R., Cayado-Gutierrez, N., Maccioni, M. and Cuello-Carrion, F.D. (2012) Heat Shock Proteins (HSPs) Based Anti-Cancer Vaccines. Current Molecular Medicine, 12, 1183-1197. [Google Scholar] [CrossRef] [PubMed]
[56] Do, K., Speranza, G., Chang, L., Polley, E.C., Bishop, R., Zhu, W., et al. (2015) Phase I Study of the Heat Shock Protein 90 (HSP90) Inhibitor Onalespib (AT13387) Administered on a Daily for 2 Consecutive Days per Week Dosing Schedule in Patients with Advanced Solid Tumors. Investigational New Drugs, 33, 921-930. [Google Scholar] [CrossRef] [PubMed]
[57] Randazzo, M., Terness, P., Opelz, G. and Kleist, C. (2012) Active‐specific Immunotherapy of Human Cancers with the Heat Shock Protein Gp96-Revisited. International Journal of Cancer, 130, 2219-2231. [Google Scholar] [CrossRef] [PubMed]
[58] Wang, X., Kazim, L., Repasky, E.A. and Subjeck, J.R. (2001) Characterization of Heat Shock Protein 110 and Glucose-Regulated Protein 170 as Cancer Vaccines and the Effect of Fever-Range Hyperthermia on Vaccine Activity. The Journal of Immunology, 166, 490-497. [Google Scholar] [CrossRef] [PubMed]
[59] 贺越, 王秀梅. 非同源末端连接中DNA连接酶IV抑制剂研究进展[J].陕西医学杂志, 2023, 52(3): 358-361.
[60] Kopa, P., Macieja, A., Pastwa, E., Majsterek, I. and Poplawski, T. (2021) DNA Double-Strand Breaks Repair Inhibitors Potentiates the Combined Effect of VP-16 and CDDP in Human Colorectal Adenocarcinoma (LoVo) Cells. Molecular Biology Reports, 48, 709-720. [Google Scholar] [CrossRef] [PubMed]

为你推荐